CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Verseon Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Verseon Corp
47071 Bayside Parkway
Phone: (510) 225-9000p:510 225-9000 Fremont, CA  94538-6517  United States Fax: (510) 225-9001f:510 225-9001
This company is no longer actively traded on any major stock exchange.
Business Summary
Verseon Corporation is a pharmaceutical company. The Company's platform models interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through the pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology. The Company's platform generates a range of drug-like, synthesizable compounds, which are then computationally tested against a disease-causing protein to identify the binders, the drug candidates that could potentially treat the disease. These computationally designed candidates are synthesized and sent through a series of disease specific in vitro and in vivo tests to identify the candidates for clinical testing in humans.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201912/31/2018YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Thomas A.Hecht
Chief Executive Officer, Founder, Executive Director AdityoPrakash
Founder, Chief Financial Officer, Chief Operating Officer, Executive Director EnikoFodor
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Edammo, Inc.
VERS
VSN

General Information
Number of Employees: 14 (As of 12/31/2014)
Outstanding Shares: 159,694,988 (As of 7/8/2019)
Stock Exchange: LON
Fax Number: (510) 225-9001


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023